> Back to JHP Titles
Impact of a heartburn and ulcer care
education program on employee productivity and medication
use
Theresa Rose, BPR, Medavie Blue Cross, Moncton, New
Brunswick, Canada
Paula Grossman, RN, Medavie Blue Cross, Moncton, New Brunswick, Canada
Lorilee Pontone, BSc. Phm, Abbott Laboratories Ltd., Mississauga, Ontario,
Canada
John McCormick, PhD, McKesson Phase 4 Solutions, Toronto, Ontario, Canada
1. O’Connor H, Sebastian S. The burden of Helicobacter
pylori infection in Europe. Aliment Pharmacol Ther 2003;18(Suppl.
3):38-44.
2. Frank L, Kleinman L, Ganoczy D, McQuaid K, Sloan S, Eggleston A et al. Upper
gastrointestinal symptoms in North America. Prevalence and relationship to
healthcare utilization and quality of life. Dig Dis Sci 2000; 45: 809-18.
3. Chaun H. Update on the role of H pylori infection in gastrointestinal disorders.
Can J Gastroenterol 2001;15:251-5.
4. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofmann JJ. The burden of illness
of gastro-oesophageal reflux disease: impact on work productivity. Aliment
Pharmacol Ther 2003;17:1309-17.
5. Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of
upper gastrointestinal symptoms in the Canadian population: findings from the
DIGEST study. Am J Gastroenterol 1999; 94: 2845-54.
6. Mason J, Hungin APS. Review article: gastro-oesophageal reflux disease – the
health economic implications. Aliment Pharmacol Ther 2005;22 (Suppl. 1):20-31.
7. Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R et al.
The economic impact of GERD and PUD: examination of direct and indirect costs
using a large integrated employer claims database. Curr Med Res Opin 2005;21:535-44.
8. Davies R, Crabbe D, Roderick P, Goddard JR, Raftery J, Patel P. A simulation
to evaluate screening for Helicobacter pylori infection in the prevention of
peptic ulcers and gastric cancers. Health Care Manag Sci. 2002;5:249-58.
9. Sandler R, Everhart J, Donowitz M et al. The burden of selected digestive
diseases in the United States. Gastroenterology 2002;122:1500-11.
10. Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the United
States. Am J Gastroenterol 1997;92:614-20.
11. Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson PS; Escobedo S,
Grace E. Treating Helicobacter pylori infection in primary care patients with
uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter
pylori positive (CADET-Hp) randomized trial. BMJ 2002;324:1012-6.
12. Henke CJ, Levin TR, Henning JM, Potter LP. Work loss costs due to peptic
ulcer disease and gastroesophageal reflux disease in a health maintenance organization.
Am J Gastroenterol 2000; 95:788-792.
13. Ott MG, Zober A, Messerer P, Riemann JF, Schilling D. Illness experience
before and after an initiative to identify, treat, and prevent Helicobacter
pylori-related diseases in the workplace. J Occup Environ Med. 2004;46:227-33.
14. Leodolter A, Nocon M, Kulig SN, Malfertheiner P, Labenz J. Gastro esophageal
reflux disease is associated with absence from work: Results from a prospective
cohort study. World J Gastroenterol 2005; 11: 7148-7151.
15. Hunt RH, Fallone CA, Thomson AB. Canadian Helicobacter pylori consensus
conference update: Infections in adults. Canadian Helicobacter Study Group.
Can J Gastroenterol 1999; 13: 213-7.
16. Hollander, M., and D. A. Wolfe, Nonparametric Statistical Methods, Wiley,
1973.
17. Brouwer WB, Koopmanschap MA. The friction-cost method: replacement for
nothing and leisure for free. Pharmacoeconomics 2005; 23: 105-11.
18. Statistics Canada (http://www.statcan.ca). Earnings, average weekly by
province and territory, 2005.
19. Provided by Medavie Blue Cross. Further information available on request.
20. Scott M, Gelhot AR. Gastroesophageal reflux disease: Diagnosis and management.
Am Fam Physician 1999; 59: 1161-1169.
|
